As showed in Figure 1(f) and Supplementary Table 1–2, FAM46A levels were correlated with the FIGO stage (P = 0.001), and differentiation-state (P = 0.009) in patients with ovarian cancer. This evidence concerns the gene TENT5A and ovarian cancer.